Rezolute Inc
(RZLT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RZLT | AZN | AMGN | GILD | BMY |
| Company | Rezolute Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 3.06 | 200.08 | 365.14 | 148.90 | 60.60 |
| High | 3.52 | 204.92 | 368.51 | 157.29 | 61.08 |
| Low | 2.95 | 199.19 | 361.00 | 147.38 | 59.66 |
| Latest | 3.38 | 204.36 | 366.46 | 156.16 | 59.93 |
| Change | +0.31 | +10.96 | +1.81 | +8.93 | -0.93 |
| % Change | +10.10% | +5.67% | +0.50% | +6.07% | -1.53% |
| Volume | 4,673,247 | 2,765,314 | 1,875,086 | 8,872,121 | 7,081,618 |
| 20-Day Average Volume | 3,176,417 | 4,627,839 | 3,145,438 | 8,498,407 | 13,428,051 |
| Previous Close | 3.07 | 193.40 | 364.65 | 147.23 | 60.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.14 | 188.12 | 349.56 | 138.96 | 56.71 |
| 20-Day Raw Stochastic | 84.19% | 97.24% | 68.77% | 95.30% | 78.01% |
| 20-Day Relative Strength | 47.63 | 64.83 | 60.17 | 72.99 | 65.47 |
| Weighted Alpha | +142.86 | +47.78 | +31.76 | +60.57 | +22.76 |
| Today's Opinion | 64% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 64% Buy | 56% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +19.07% since 02/04/26 | +8.93% since 02/04/26 | -0.24% since 02/04/26 | +6.39% since 02/04/26 | +4.44% since 02/04/26 |
| Low | 2.80 on 02/05/26 | 186.58 on 02/05/26 | 361.00 on 02/11/26 | 145.87 on 02/05/26 | 58.00 on 02/05/26 |
| High | 3.47 on 02/11/26 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | +31.75% since 01/09/26 | +7.86% since 01/09/26 | +12.03% since 01/09/26 | +28.47% since 01/09/26 | +7.73% since 01/09/26 |
| Low | 2.36 on 01/13/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 3.65 on 01/23/26 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | -65.49% since 11/11/25 | +14.59% since 11/11/25 | +7.94% since 11/11/25 | +26.94% since 11/11/25 | +23.52% since 11/11/25 |
| Low | 1.07 on 12/11/25 | 174.46 on 11/12/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 11.16 on 12/10/25 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -41.67% since 08/11/25 | +37.83% since 08/11/25 | +28.14% since 08/11/25 | +29.14% since 08/11/25 | +31.03% since 08/11/25 |
| Low | 1.07 on 12/11/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 11.46 on 11/10/25 | 204.92 on 02/11/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 284,675 | 299,945,568 | 196,357,104 | 182,665,312 | 123,895,928 |
| Shares Outstanding, K | 92,728 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -74,410,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -18,150,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 0.46 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.18 on 11/06/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/11/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.57 | 17.20 | 18.52 | 9.88 |